Integration of new or experimental treatment options and new approaches to clinical trials.

Quinn, M; Pfisterer, J; Avall-Lundqvist, E; Bookman, M; Bowtell, D; Casado, A; Cervantes, A; Grenman, S; Harper, P; Oza, A; Pecorelli, S; Pujade-Lauraine, E; Trimble, E; Vasey, P; Wagner, U

Quinn, M; Pfisterer, J; Avall-Lundqvist, E; Bookman, M; Bowtell, D; Casado, A; Cervantes, A; Grenman, S; Harper, P; Oza, A; Pecorelli, S; Pujade-Lauraine, E; Trimble, E; Vasey, P; Wagner, U.

Affiliation

Quinn M; Oncology Unit, Royal Women's Hospital, Carlton, Australia. maquinn@unimelb.edu.au

Ann Oncol ; 16 Suppl 8: viii30-viii35, 2005.

Article in En | MEDLINE | ID: mdl-16239234

Subject(s)

Ovarian Neoplasms/therapy; Clinical Trials as Topic/methods; Combined Modality Therapy; Female; Humans; Research Design

Search on Google

Add to My VHL

XML

PubMed Links

Collection: 01-internacional Database: MEDLINE Main subject: Ovarian Neoplasms Type of study: Guideline Limits: Female / Humans Language: En Journal: Ann Oncol Journal subject: NEOPLASIAS Year: 2005 Document type: Article Affiliation country: Australia Country of publication: United kingdom

Search on Google

Add to My VHL

XML

PubMed Links